Home › Overweight › Rhode Island
Pag-aaral pangklinika para sa Overweight sa Rhode Island
13 pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa mga site sa Rhode Island.
Mga Lungsod sa Rhode Island
Opisyal na teksto ng pag-aaral (English)
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Clinical Res Collaborative, Cumberland
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07720271Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- University Gastroenterology, Providence
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- University Gastroenterology, Providence
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937086Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Velocity Clinical Research - Providence, East Greenwich
Nagre-recruitPhase 3
Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Velocity Clinical Research - Providence, East Greenwich
Nagre-recruitPhase 3
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684144Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, East Greenwich
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Velocity Clinical Research - Providence, East Greenwich
Nagre-recruitPhase 3
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684235Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
- Women and Infants Hospital of Rhode Island, Providence
Nagre-recruit
Edad 18 hanggang 45 · Kababaihan · Na-update Hun 24, 2026 · NCT05124808Brain and Behavior Influences on Obesity Development From Infancy Through Childhood
- Rhode Island Hospital, Providence
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 7 hanggang 12 · Lahat ng kasarian · Na-update May 7, 2026 · NCT06861868Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
- The Weight Control and Diabetes Research Center of The Miriam Hospital & Brown University, Providence
Nagre-recruit
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Peb 4, 2026 · NCT07228130Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight
- Weight Control and Diabetes Research Center, Providence
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 23, 2026 · NCT07363616Weight Management Intervention in College: A Pilot
- The Miriam Hospital, Providence
Nagre-recruit
Edad 18 hanggang 29 · Lahat ng kasarian · Na-update Okt 1, 2025 · NCT06994923Control Systems Engineering for Weight Loss Maintenance
- Miriam Hospital Weight Control and Diabetes Resarch Center, Providence
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Abr 2, 2024 · NCT06244888Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.